News

Perrigo Company asserted that it has received final approval from the U.S Food and Drug Administration for the store brand OTC equivalent of Muciinex DM Maximum Strength Guaifenesin and…
Read More...

Veloxis Pharmaceuticals asserted that it has submitted a supplemental New Drug Application to the U.S Food and Drug Administration seeking new indication for ENVARSUS XR (tacrolimus…
Read More...

Ligand Pharmaceuticals signed a license agreement extending Roivant sciences exclusive global rights to develop and commercialize LGD-6972, ligand's glucagon receptor antagonist. As…
Read More...

Biohaven Pharmaceuticals asserted that it has enrolled the first patient in a Phase 3 Clinical Trial of Zydis that is a orally dissolving tablet formulation of rimegepant for the…
Read More...

Apexigen which is clinical-stage bio pharmaceutical company and the Pediatric Brain Tumor Consortium (PBTC) announced a Clinical trial collaboration to assess and evaluate Apexigen's …
Read More...

Citius Pharmaceuticals which is a specialty pharmaceutical company announced that the Company is finalizing a higher potency corticosteroid in its steroid/anesthetic topical formulation…
Read More...

Forendo Pharma which is a drug development company developing novel oral treatments for endometriosis patients asserted the appointment of David Colpman as a Non-executive Director to…
Read More...

23andMe which is the leading personal genetics company received FDA Authorization for a direct-to-consumer genetic test for cancer risk.The authorization allows 23andMe to provide…
Read More...

Theratechnologies and its partner TaiMed Biologics, Inc. (TaiMed) asserted that the U.S. Food and Drug Administration (FDA) has granted approval of Trogarzo (ibalizumab-uiyk) Injection.…
Read More...

The U.S Food and Drug Administration has sanctioned Trogarzo which is a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications…
Read More...

The U.S Food and Drug Administration has sanctioned the Imugen Babesia microti Arrayed Fluorescent Immunoassay (AFIA), for the detection of antibodies to Babesia microti (B. microti) in…
Read More...

Contego Medical has affirmed the enrollment in the PERFORMANCE I Trial, a clinical trial designed to evaluate the safety and feasibility of the Neuroguard IEP 3-in-1 Carotid Stent and…
Read More...

Magenta Therapeutics which is a biotechnology company developing therapeutics to enhance and extend the use of curative bone marrow transplant for more patients and Heidelberg Pharma AG…
Read More...

City of Hope scientists and doctors have discerned a more effective treatment for patients with Chronic myelogenous leukemia using a drug that was developed at the Institution to…
Read More...

GlycoMimetics unveiled design for a randomized, double blind, placebo-controlled Phase 3 Clinical Trial to evaluate GMI-1271 in combination with MEC (Mitoxantrone, etoposide and Ara-C)…
Read More...

Sagent Pharmaceuticals asserted the voluntary nationwide recall of ten lots of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g. The products were…
Read More...

Sinovac Biotech which is a provider of bio-pharmaceutical products in China has plans to accentuate the corporate governance and management of Sinovac Biotech Co., Ltd, the main…
Read More...

Biopharmaceutical company, Moleac that is focused on research and development of new medicines for central nervous system (CNS) diseases and injuries, today announced that the U.S. Food…
Read More...

Prometic Life sciences asserted that the U.S Food and Drug Adminstration has granted a Rare Pediatric Disease Designation to its Inter-Alpha-Inhibitor-Proteins for the treatment of…
Read More...

Vanda Pharmaceuticals asserted that HETLIOZ which is a circadian regulator exhibited significant and clinically meaningful benefits in symptoms of jet lag disorder. Jet lag disorder…
Read More...